Replies to post #75814 on Canopy Growth Corp (WEED)

[Wo]

Adding to the speculation for 2018...
http://www.beckley-canopy.com/research.html

RESEARCH AND DEVELOPMENT Cannabis-based medicines offer a disruptive alternative to many of the standard treatments emanating from the $1.1 trillion dollar pharmaceutical industry. Thousands of years of evidence, millions of testimonies and dozens of clinical trials continue to prove that cannabis is a safe and effective treatment for a broad range of mental and physical diseases. Yet physician acceptance and subsequent consumer access to cannabis therapies continues to be restricted by the relative lack of rigorous clinical research data. A glaring clinical need exists for cannabis-based medicines that meet pharmaceutical standards of quality, consistency, and scientific validation.{...}

and,

{...}ONGOING RESEARCH BECKLEY CANOPY’s first IP generating research in humans is already underway: a brain imaging trial looking at the effects of a proprietary cannabinoid formulation in the treatment of a major indication. Additional research and product development programs are scheduled to start in 2018. As IP positions are secured, further information will be provided.

[Att_for_life]

Feds already rescheduled CBD...